Ameliorating Drug Shortages In Pakistan

Shahid Mahmood
Additional contact information
Shahid Mahmood: Pakistan Institute of Development Economics, Islamabad

No 2022:37, PIDE Policy View Point from Pakistan Institute of Development Economics

Abstract: n mid-March 2022, a letter by Pakistan Young Pharmacist Association (PYPA) caught the headline of major newspapers in Pakistan 2 . The letter, written in the context of the prevalent shortage of paracetamol, more or less alleged that the drug manufacturing companies were deliberately causing the shortages. They argued that drug manufacturers wanted to compel customers to buy a higher dose of the said drug (665 mg) since it had a significantly higher price than lower doses.

Keywords: Ameliorating Drug (search for similar items in EconPapers)
Pages: 4 pages
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://file.pide.org.pk/uploads/pv-37-amelioratin ... ages-in-pakistan.pdf First Version, 2022 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pid:pviewp:2022:37

Access Statistics for this paper

More papers in PIDE Policy View Point from Pakistan Institute of Development Economics Contact information at EDIRC.
Bibliographic data for series maintained by Khurram Iqbal ().